Womancart Limited (NSE:WOMANCART)

Theseus Pharmaceuticals Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2024	FY 2023
Period Ending	Sep 30, 2024	Mar 31, 2024	Mar 31, 2023
Cash & Equivalents	131.17	46.72	7.6
Cash & Short-Term Investments	131.17	46.72	7.6
Cash Growth	-	514.44%	-
Receivables	43.09	42.88	3.42
Inventory	264.24	115.81	30.86
Other Current Assets	101.69	31.67	5.33
Total Current Assets	540.18	237.08	47.22
Property, Plant & Equipment	64.78	23.99	6.98
Other Intangible Assets	2.99	2.24	0.91
Long-Term Deferred Tax Assets	0.67	0.48	0.02
Total Assets	608.62	263.79	55.13
Accounts Payable	45.15	19.9	6.89
Accrued Expenses	-	2.98	1.83
Short-Term Debt	161.06	62.23	5.15
Current Portion of Long-Term Debt	-	-	0.85
Current Income Taxes Payable	-	-	1.69
Other Current Liabilities	12.18	9.65	-
Total Current Liabilities	218.39	94.75	16.41
Long-Term Debt	9.65	3.76	7.22
Long-Term Deferred Tax Liabilities	-	0.11	-
Other Long-Term Liabilities	-0	0	-0
Total Liabilities	228.04	98.62	23.62
Common Stock	49.5	42.08	11.08
Retained Earnings	246.97	123.09	20.43
Shareholders' Equity	380.58	165.17	31.51
Total Liabilities & Equity	608.62	263.79	55.13
Total Debt	170.71	65.99	13.22
Net Cash (Debt)	-39.54	-19.27	-5.61
Net Cash Per Share	-9.14	-5.96	-2.03
Filing Date Shares Outstanding	4.57	4.21	3.1
Total Common Shares Outstanding	4.57	4.21	2.77
Working Capital	321.78	142.34	30.81
Book Value Per Share	83.16	39.25	11.37
Tangible Book Value	377.28	162.93	30.6
Tangible Book Value Per Share	82.51	38.72	11.05

Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.